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1.1. Document Development Process
1.1.1. Writing Committee Organization
The writing committee was selected to represent the
American College of Cardiology (ACC) and the Heart
Rhythm Society (HRS) and included a cardiovascular
training program director, an electrophysiology (EP)
program training director, early-career experts,
highly experienced specialists representing both the
academic and community-based practice settings,
and physicians experienced in deﬁning and applying
training standards according to the 6 general compe-
tency domains promulgated by the Accreditation
Council for Graduate Medical Education (ACGME) and
the American Board of Medical Specialties (ABMS) and
endorsed by the American Board of Internal Medicine
(ABIM). The ACC determined that relationships with
industry or other entities were not relevant to the
creation of this general cardiovascular training state-
ment. Employment and afﬁliation details for authors
and peer reviewers are provided in Appendixes 1 and 2,
respectively, along with disclosure reporting cate-
gories. Comprehensive disclosure information for all
authors, including relationships with industry and
other entities, is available as an online supplement to
this document.1.1.2. Document Development and Approval
The writing committee developed the document,
approved it for review by individuals selected by the
ACC andHRS, and addressed the reviewers’ comments.
The document was revised and posted for public
comment from December 20, 2014, to January 6, 2015.
Authors addressed the additional comments to com-
plete the document. The ﬁnal document was approved
by the Task Force, COCATS Steering Committee, and
ACC Competency Management Committee; ratiﬁed
by the ACC Board of Trustees in March, 2015; and
endorsed by the Heart Rhythm Society. This document
is considered current until the ACC Competency
Management Committee revises or withdraws it.
1.2. Background and Scope
The diagnosis and management of cardiac arrhyth-
mias and conduction disorders are common and
important components of the practice of clinical car-
diology and are thus part of the core competency
training of a clinical cardiologist. Clinical cardiac
electrophysiologists are responsible for the compre-
hensive care of patients with more complex arrhyth-
mias, along with advanced testing and invasive
therapies. Clinical cardiac electrophysiologists are
trained to implant cardiac electrical devices, perform
diagnostic EP procedures and therapeutic catheter
ablation procedures, and employ pharmacological
agents to treat patients with complex arrhythmias
and conduction disturbances. Cardiac implantable
electrical devices (CIEDs) include pacemakers, im-
plantable cardioverter-deﬁbrillators (ICDs), cardiac
resynchronization therapy (CRT) devices, implantable
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(ILRs). For this document, implantable hemodynamic
monitors and ILRs are excluded from the minimum
training requirements. All cardiovascular trainees are
expected to understand their indications for clinical use
and to learn how to interpret the generated results in
providing clinical care as part of their basic training.
The Task Force was charged with updating previously
published standards for training fellows in cardiology
enrolled in cardiac fellowship programs (1–4) on the basis of
changes in the ﬁeld since 2008 (2) and as part of a broader
effort to establish consistent training criteria across all as-
pects of cardiology. This document does not provide spe-
ciﬁc guidelines for advanced cardiac electrophysiology
training. Recommendations for advanced training in clin-
ical cardiac electrophysiology (CCEP) are provided in the
2006 Clinical Competence Statement (5). The 2006 Clinical
Competence Statement is currently being revised and
retitled as the Electrophysiology Advanced Training
Statement. In its revised form, it will provide detailed
recommendations for the electrophysiology training
required to obtain ABIM certiﬁcation. The Task Force also
updated previously published standards to address the
evolving framework of competency-based medical educa-
tion described by the ACGME Outcomes Project and the 6
general competencies endorsed by ACGME and ABMS. The
background and overarching principles governing fellow-
ship training are provided in the COCATS 4 Introduction,
and readers should become familiar with this foundation
before considering the details of training in a subdisci-
pline like electrophysiology. The Steering Committee
and Task Force recognize that implementation of these
changes in training requirements will occur incrementally.
For most areas of adult cardiovascular medicine, 3
levels of training are delineated:
n Level I training, the basic training required of trainees to
become competent consultant cardiologists, is required
of all fellows in cardiology, and can be accomplished as
part of a standard 3-year training program in cardiology.
n Level II training refers to additional training in 1 or
more areas that enables some cardiologists to perform
or interpret speciﬁc procedures or render more
specialized care for patients and conditions. This level
of training is recognized for those areas in which an
accepted instrument or benchmark, such as a qualifying
examination, is available to measure speciﬁc knowl-
edge, skills, or competence. Level II training in selected
areas may be achieved by some trainees during the
standard 3-year cardiovascular fellowship, depending
on the trainees’ career goals and use of elective rota-
tions. It is anticipated that during a standard 3-year
cardiovascular fellowship training program, sufﬁcient
time will be available to receive Level II training in aspeciﬁc subspecialty. In the case of EP, Level II training
is required for individuals to provide specialized
arrhythmia and CIED management, including implan-
tation, interrogation, and programming of pacemakers
and ILRs, and interrogation and programming of
implanted deﬁbrillators. Those cardiovascular fellows
seeking to implant ICDs and CRT devices without sub-
specialty board certiﬁcation in CCEP are required to
take an additional year of dedicated training beyond
the 3 years required for cardiovascular training.
n Level III training requires additional training and
experience beyond the cardiovascular fellowship for the
trainee to acquire specialized knowledge and experience
in performing, interpreting, and training others to
perform speciﬁc procedures or render advanced
specialized care for speciﬁc procedures at a high level of
skill. In the case of EP, Level III training is required of
individuals seeking subspecialty board certiﬁcation
(CCEP). As noted previously, those cardiovascular fel-
lows seeking to implant ICDs and CRT devices without
subspecialty board certiﬁcation in CCEP are required to
take an additional year of dedicated training beyond the
3 years required for cardiovascular training.
The recommended number of cases, procedures, and
experiences is based on published guidelines, compe-
tency statements, and the experience and opinions of the
members of the writing group. It is assumed that training
is directed by appropriately trained mentors in
an ACGME–accredited program and that satisfactory
completion of training is documented by the program
director. The number and types of encounters and the
duration of training required for fellows are summarized
in Section 4. Level III training is described here only in
broad terms to provide context for trainees and clarify
that these advanced competencies are not covered during
the cardiovascular fellowship. The additional exposure
and requirements for Level III training will be addressed
in a subsequent, separately published, Advanced Training
Statement, previously described in the 2006 Clinical
Competency Statement (5).
2. GENERAL STANDARDS
Three organizations—the ACC, American Heart Associa-
tion, and HRS—have addressed training requirements and
guidelines for the following topic areas: permanent pace-
maker selection, implantation, and follow-up (6,7); im-
plantation and follow-up of ICDs (8,9); training in catheter
ablation procedures (10,11); and educational objectives for
fellowship training in CCEP (2,12,13). The recommenda-
tions are congruent and address faculty, facility require-
ments, emerging technologies, and practice. We strongly
recommend that candidates for the ABIM examination for
certiﬁcation in cardiovascular diseases, as well as those
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view the speciﬁc requirements of the ABIM (14,15).
The intensity of training and required resources
vary according to the level of training provided. Cardio-
vascular fellowship programs do not have to satisfy the
requirements regarding facilities and faculty for training
in EP (10,11) unless they also have an ABIM–accredited EP
training program designed to provide Level III training.
Eligibility for the ABIM CCEP examination requires
that training take place in a program accredited by the
ACGME (14).
2.1. Faculty
Faculty involved in training in arrhythmia diagnosis and
management, cardiac pacing, and electrophysiology
should include specialists who are skilled in the phar-
macological, catheter-based, and surgical aspects of pac-
ing and EP and are knowledgeable about the risks to the
patient and medical personnel associated with radiation
exposure. This faculty should include at least 1 board-
certiﬁed electrophysiologist (CCEP) or 1 who possesses
equivalent qualiﬁcations. A physician is considered to
have equivalent qualiﬁcations if he or she trained in a
similar environment for a similar period of time and
performed the required number of procedures.
2.2. Facilities
Facilities should include a cardiac EP laboratory that
provides a safe, sterile, and effective environment for
invasive diagnostic EP studies, catheter ablation pro-
cedures, and CIED implantation. In addition, outpatient
clinical facilities should be available for implantation of
CIEDs, training in the consultative aspects of arrhythmia
management, and device therapy.
2.3. Equipment
EP laboratories require ﬂuoroscopy and specialized
equipment for the safe performance of diagnostic pro-
cedures, catheter ablation procedures, and CIED implan-
tation. This equipment includes EP pacing and recording
systems, radiofrequency generators, and deﬁbrillators.
Additional equipment is needed in programs performing
lead extraction (16).
2.4. Ancillary Support
Ancillary support should be available to perform EP and
ablation procedures and to implant CIEDs, including
general anesthesia and surgical backup in the event of
complications requiring surgical intervention.
3. TRAINING COMPONENTS
3.1. Didactic Program
Didactic instruction may take place in a variety of for-
mats, including but not limited to lectures, conferences,journal clubs, grand rounds, clinical case presentations,
and patient safety or quality improvement conferences.
The electrocardiographic (ECG) manifestations of ar-
rhythmias should be taught on a regular basis during
formal ECG conferences.
3.2. Clinical Experience
Rotation on an arrhythmia service is an essential
component of all levels of EP training. A Level I trainee
should gain ﬁrst-hand experience as a consultant in
arrhythmia management. It is important that the
arrhythmia consultation service have a robust patient mix
and acuity level. During the required 2 months on the
consultation arrhythmia service, Level I trainees should
evaluate 1 or more inpatient arrhythmia consultations
daily in addition to providing follow-up care after initial
consultation. In addition to participating in arrhythmia
consultations, it is also important for Level I trainees to
observe EP procedures including diagnostic EP studies,
placement of ILRs, catheter ablation procedures including
atrial ﬁbrillation ablation procedures, and device im-
plantation procedures (permanent pacemakers, ICDs, and
CRTs). Level I trainees should also observe a number of
interrogations of implanted devices (permanent pace-
makers, ICDs, and CRTs) and gain a basic understanding
of concepts involved in programming and interrogating
implantable devices.
Level II and III training require robust clinical experi-
ences in the outpatient setting, inpatient and inpatient
consultation setting, and EP laboratory. In each of these
clinical settings, trainees assist in patient care in a su-
pervised setting that provides for patient-centered edu-
cation in all aspects of arrhythmia management.
3.3. Hands-On Experience
Hands-on experience is important for training in
arrhythmia and CIED management. Trainees in cardiology
should spend a minimum of 2 months on an arrhythmia
service to acquire the core competencies (Level I). During
this period or during rotations in the coronary care unit
and cardiac catheterization laboratory, trainees should
perform cardioversion procedures; implant, evaluate, and
adjust temporary pacemakers; and interpret the results of
tilt-table testing.
Level II knowledge and skills can typically be obtained
within 6 months dedicated training by the arrhythmia
service. During this additional training, trainees should
perform cardioversion procedures; implant, evaluate, and
adjust temporary pacemakers; learn how to interrogate
and troubleshoot implantable devices (permanent pace-
makers, ICDs, and CRTs); perform and interpret the re-
sults of tilt-table testing; implant ILRs; and spend time in
the device and arrhythmia clinic. Level II trainees may
use part of this dedicated training period to learn to
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The minimum number of such procedures is provided
later in this document.
Level III training in cardiac EP requires additional
training beyond the standard 3-year cardiovascular
fellowship and typically requires 24 months of exposure to
advanced cardiac electrophysiology, including a consid-
erable amount of time in the EP laboratory performing
speciﬁc procedures. Level III training is required of in-
dividuals seeking subspecialty board certiﬁcation in CCEP.
4. SUMMARY OF TRAINING REQUIREMENTS
4.1. Development and Evaluation of Core Competencies
Training and requirements in cardiac arrhythmia diag-
nosis, pacing, and electrophysiology address the 6 general
competency domains promulgated by the ACGME/
American Board ofMedical Specialties and endorsed by the
ABIM. These competency domains are: medical knowl-
edge, patient care and procedural skills, practice-based
learning and improvement, systems-based practice,
interpersonal and communication skills, and profession-
alism. The ACC has used this structure to deﬁne the com-
ponents of the core clinical competencies for cardiology.
The curricular milestones for each competency and
domain also provide a developmental roadmap for fellows
as they progress through various levels of training and
serve as an underpinning for the ACGME/ABIM reporting
milestones. The ACC has adopted this format for its com-
petency and training statements, career milestones, life-
long learning, and educational programs. Additionally, it
has developed tools to assist physicians in assessing,
enhancing, and documenting these competencies.
Table 1 delineates each of the 6 competency domains as
well as their associated curricular milestones for training
in cardiac arrhythmias and electrophysiology. The mile-
stones are categorized into Level I, II, and III training (as
previously deﬁned in this document) and indicate the
stage of fellowship training (12, 24, or 36 months, and
additional time points) by which the typical cardiovas-
cular trainee should achieve the designated level. Given
that programs may vary with respect to the sequence of
clinical experiences provided to trainees, the milestones
at which various competencies are reached may also vary.
Level I competencies may be achieved at earlier or later
time points. Acquisition of Level II skills requires addi-
tional training, and acquisition of Level III skills requires
training in a dedicated CCEP program. The table also de-
scribes examples of evaluation tools suitable for assess-
ment of competence in each domain.
4.2. Number of Procedures and Duration of Training
The speciﬁc competencies for Levels I, II, and III are
delineated in Table 1. Level I competencies must beobtained by all fellows during the 3-year cardiovas-
cular disease fellowship training program. Level II com-
petencies may be obtained during the cardiovascular
disease fellowship by selected fellows depending on their
career focus and elective experiences. Level III compe-
tencies are noted so that fellows are aware of the com-
petencies for which additional, advanced training beyond
the standard 3-year fellowship is required. Details for
advanced training will be included in an updated version
of the 2006 Clinical Competence Statement on Invasive
Electrophysiology Studies, Catheter Ablation, and Car-
dioversion (5), which is currently under revision. The
minimum duration of training and volume of procedures
required for Level I and II training in CCEP are summa-
rized in Tables 2 and 3. Although these minimum training
durations and numbers of procedures are typically
required to obtain the competency levels, trainees must
also demonstrate achievement of the competencies as
assessed by the outcomes evaluation measures. A brief
discussion of the competencies and training requirements
follows.
4.2.1. Level I Training Requirements
Level I training should occupy at least 2 months on a CCEP
rotation designed to acquire knowledge, skills, and
experience in the diagnosis and management of arrhyth-
mias (Table 1). Level I training should focus on the value
of the clinical history in the diagnosis of cardiac
arrhythmias and the ECG interpretation of arrhythmias,
including differentiation of supraventricular from ven-
tricular tachycardia. Also important for Level I training is
exposure to the noninvasive diagnosis of cardiac ar-
rhythmias, including ambulatory ECG monitoring (see
COCATS 4 Task Force 2 report), event recorders, ILRs,
exercise testing for arrhythmia assessment, and tilt-table
testing. Exposure to invasive EP studies (including mea-
surements of AH and HV intervals, and basic activation
sequences) should be provided in Level I training to allow
understanding of the role of invasive EP testing in diag-
nosis of cardiac arrhythmias. The Level I trainee should
understand the basic concepts of catheter ablation,
including indications, contraindications, techniques, and
potential complications. Similarly, the Level I trainee
should understand the basic concepts of CIEDs, including
the indications, techniques, and potential complications
of ICDs and biventricular pacemakers. Knowledge of the
fundamentals of cardiac pacing should encompass
recognition of normal and abnormal pacemaker function
(2); pacing modes; and techniques of interrogation, pro-
gramming, and surveillance of pacemakers and ICDs.
Instruction in cardiac pacing should emphasize the
indications, cost-effective use, and limitations of
these devices. Level I trainees should understand the
proper use of anticoagulant and antiarrhythmic agents,
TABLE 1 Core Competency Components and Curricular Milestones for Training in Cardiac Arrhythmias and Electrophysiology
Competency Component Milestones (Months)
MEDICAL KNOWLEDGE 12 24 36 Add
1 Know the mechanism and characteristics of normal sinus rhythm and of sinus node dysfunction. I
2 Know the pathophysiology, differential diagnosis, clinical signiﬁcance, and approach to management of
re-entrant tachycardia (atrioventricular nodal re-entrant tachycardia; atrioventricular reciprocating
tachycardia), ectopic atrial tachycardias, and accelerated atrioventricular junctional rhythm.
I
3 Know the pathophysiology, differential diagnosis, clinical signiﬁcance, and approach to management of
atrial ﬁbrillation and ﬂutter, including the assessment of stroke and bleeding risk, indications of
anticoagulation, and selection of anticoagulant medications.
I
4 Know the risk factors for stroke and for bleeding in patients with atrial ﬁbrillation or atrial ﬂutter, as well as
the indications for, and use of, anticoagulant medications.
I
5 Know the pathophysiology, differential diagnosis, clinical signiﬁcance, and approach to management of
sustained and nonsustained ventricular tachyarrhythmias.
I
6 Know the pathophysiology, differential diagnosis, and approaches to risk stratiﬁcation and management of
sudden cardiac death and cardiac arrest, including sudden cardiac death in athletes.
I
7 Know the types, mechanisms, differential diagnosis, clinical signiﬁcance, and approach to management of
atrioventricular dissociation and atrioventricular heart blocks (ﬁrst, second, and third degree).
I
8 Know the physical examination characteristics of arrhythmias (e.g., ﬁndings of atrioventricular
dissociation).
I
9 Know the signiﬁcance of underlying structural or congenital heart disease in the likelihood and signiﬁcance
of cardiac arrhythmias, including sudden death risk, and their impact in clinical management decisions.
I
10 Know the indications, contraindications, and clinical pharmacology of antiarrhythmic medications,
including drug–drug and drug–device interactions and proarrhythmia potential (including acquired long QT
syndrome).
I
11 Know the indications and limitations of noninvasive testing in the diagnosis and management of patients
with arrhythmias: electrocardiogram, ambulatory, event, implantable loop recorder, and tilt-table testing.
I
12 Know the indications for, and limitations and complications of, invasive electrophysiological testing, as
well as catheter ablation for cardiac arrhythmias.
I
13 Know the indications and contraindications for permanent pacemaker placement, cardiac resynchronization
therapy, and implantable cardioverter-deﬁbrillator placement.
I
14 Know the pathophysiology, differential diagnosis, natural history, and approach to management of
syncope, including neurocardiogenic causes and syncope in athletes.
I
15 Know the mechanisms, ﬁndings, clinical signiﬁcance, and approach to management of ventricular pre-
excitation.
I
16 Know the pathology, clinical signiﬁcance, and approach to evaluation (including the role of genetic testing)
and management of inherited diseases that may cause cardiac arrhythmias due to ion channel
abnormalities or structural changes in the heart (including the long QT syndrome, Brugada syndrome,
arrhythmogenic right ventricular dysplasia, hypertrophic dilated cardiomyopathy, and myotonic
dystrophy).
I
17 Know the principles and practice of radiation safety as applied to the evaluation and management of
cardiac electrical disorders.
I
18 Know the basic principles of programming and interrogating implanted devices (permanent pacemakers,
implantable cardioverter-deﬁbrillators, cardiac resynchronization therapies, and implantable monitors)
I
EVALUATION TOOLS: chart-stimulated recall, global evaluation, and in-training examination.
PATIENT CARE AND PROCEDURAL SKILLS 12 24 36 Add
1 Skill to evaluate and manage patients with palpitations. I
2 Skill to evaluate and manage patients with syncope. I
3 Skill to evaluate and manage patients with supraventricular tachyarrhythmias. I
4 Skill to evaluate and manage patients with atrial ﬁbrillation and ﬂutter (including rate and rhythm control
and anticoagulation strategies).
I
5 Skill to evaluate and manage patients with wide-QRS tachycardia. I
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TABLE 1 Core Competency Components, continued
Competency Component Milestones (Months)
PATIENT CARE AND PROCEDURAL SKILLS 12 24 36 Add
6 Skill to manage patients with nonsustained and sustained ventricular arrhythmias. I
7 Skill to evaluate and manage patients with bradycardia and/or heart block. I
8 Skill to perform electrical cardioversion. I
9 Skill to perform deﬁbrillation. I
10 Skill to perform tilt-table testing. II
11 Skill to perform temporary pacemaker placement. I
12 Skill to select and manage patients requiring a permanent pacemaker, implantable cardioverter-
deﬁbrillator, or biventricular pacing.
I
13 Skill to integrate the information provided in cardiac electrophysiology consultation, and reports of
procedures and device interrogation, into the overall clinical assessment of the patient and plan of
management.
I
14 Skill to perform pacemaker and implantable cardioverter-deﬁbrillator interrogation, programming, and
surveillance.
II
15 Skill to perform single- and dual-chamber permanent pacemaker implantation and manage complications,
including device infections and chronic lead failure.
II
16 Skill to perform implantation of implantable loop recorders, interpret results to guide patient
management, and manage complications.
II
17 Skill to perform implantable cardioverter-deﬁbrillator and biventricular device implantation and manage
complications.
III
18 Skill to perform and interpret invasive electrophysiological testing and carry out ablation therapy. III
19 Skill to utilize magnetic resonance imaging, computed tomography, and intracardiac echocardiography in
facilitating invasive electrophysiology and ablation therapies.
III
20 Skill to follow-up, interrogate, and troubleshoot patients with implanted devices (permanent pacemakers,
implantable cardioverter-deﬁbrillators, cardiac resynchronization therapies), including remote
interrogation.
II
21 Skill to evaluate and manage patients with cardiac arrest. I
22 Skill to prescribe and interpret the results of electrocardiographic recording devices. I
EVALUATION TOOLS: chart-stimulated recall, patient safety or quality improvement conference presentation, direct observation,
global evaluation, logbook, and simulation.
SYSTEMS-BASED PRACTICE 12 24 36 Add
1 Utilize an interdisciplinary coordinated approach for patient management, including transfer of care and
employment-related issues.
I
2 Use technology and available registries to assess appropriateness, performance, and safety of implanted
devices.
I
3 Incorporate risk/beneﬁt analysis and cost considerations in diagnostic and treatment decisions. I
EVALUATION TOOLS: chart-stimulated recall, direct observation, and multisource evaluation.
PRACTICE-BASED LEARNING AND IMPROVEMENT 12 24 36 Add
1 Identify knowledge and performance gaps and engage in opportunities to achieve focused education and
performance improvement.
I
2 Utilize decision support tools for accessing guidelines and pharmacologic information at the point of care. I
EVALUATION TOOLS: chart-stimulated recall, conference presentation, direct observation, and logbook.
PROFESSIONALISM 12 24 36 Add
1 Demonstrate sensitivity to patient preferences and end-of-life issues. I
2 Practice within the scope of expertise and technical skills. I
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TABLE 1 Core Competency Components, continued
Competency Component Milestones (Months)
PROFESSIONALISM 12 24 36 Add
3 Interact respectfully with patients, families, and all members of the healthcare team, including ancillary
and support staff.
I
EVALUATION TOOLS: chart-stimulated recall, conference presentation, and direct observation.
INTERPERSONAL AND COMMUNICATION SKILLS 12 24 36 Add
1 Communicate with and educate patients and families across a broad range of cultural, ethnic, and
socioeconomic backgrounds.
I
2 Engage in shared decision-making with patients, including decisions regarding options for diagnosis and
treatment.
I
EVALUATION TOOLS: direct observation and multisource evaluation.
Add ¼ additional months beyond the 3-year cardiovascular fellowship.
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interactions.
The cardiovascular trainee should be instructed in
and gain experience with the indications for insertion,
management, and follow-up of temporary pacemakers
(2), including measurement of pacing and sensing
thresholds, recording of intracardiac electrograms, and
recognition of procedure-related complications. The
cardiovascular trainee should also be instructed in and
gain experience with cardioversion and cardiac deﬁbril-
lation (17). Temporary pacemaker and cardioversion pro-
cedures may be performed in the cardiac catheterization
laboratory, electrophysiology laboratory, cardiac care unit,
or other critical care settings. Instruction leading to
acquisition of the core competencies required of Level I
trainees should meet the minimum procedural volumeTABLE 2
Cardiac Arrhythmia and Electrophysiology
Curriculum Training Summary for 3-Year
Cardiovascular Fellowship Training Program
Level Curriculum/Skills Time Requirement
Optional Training
in Device
Implantation
I Cardiac arrhythmia and
electrophysiology
core
2 months (in addition to
COCATS 4 Task Force 2
training requirements)
No
II Advanced noninvasive
arrhythmia
management
6 months Level II trainees
who wish
to implant
permanent
pacemakers
and ILRs may
receive this
training
during this
6-month
period of time.
ILR ¼ implantable loop recorder.criteria detailed in Table 3. These experiences and skills
should be obtained throughout the cardiovascular clinical
training period and be integrated with formal didactic ECG
conferences, core curriculum sessions, and rotation on the
arrhythmia consultation service.
4.2.2. Level II Training Requirements
Trainees who wish to have more training in cardiac EP
should be enrolled in programs that include speciﬁc
inpatient services and outpatient clinics designed for
patients requiring therapy for cardiac arrhythmias and
conduction disorders, as described for Level I; however,
in addition to ensuring a curriculum that satisﬁes the
speciﬁcs of Level I training, such programs must offer
greater intensity and exposure to a broader spectrum of
therapeutic modalities. Level II training can be accom-
plished within the scope of the 3 years of initial cardio-
vascular training. Trainees in a Level II curriculum should
actively participate in didactic activities relating more
speciﬁcally to EP, including research conferences, semi-
nars, and journal clubs with cardiac electrophysiological
disorders as a primary focus.
Level II training involves more advanced knowledge
and skills than Level I training but less than the
comprehensive training in cardiac EP required for Level
III training. Level II training typically involves 6 months
of training in mechanisms of arrhythmia; pharmacology
of antiarrhythmic and anticoagulant drugs; and nonin-
vasive and invasive techniques of diagnosis, treatment,
and longitudinal care of patients with complex
arrhythmias.
The Level II trainee should acquire the skills and
experience to manage patients with CIEDs, including
permanent pacemakers, ICDs, biventricular pacemakers,
and ILRs. Level II trainees who wish to implant
TABLE 3
Core Cardiac Arrhythmia and Electrophysiology
Curriculum Training for 3-Year Cardiovascular
Fellowship Training Program
Level Minimum Number of Procedures
Cumulative
Duration
of Training
I 5 temporary pacemakers
20 cardioversions
2 months
II For Level II training alone (without training in
pacemaker implantation)
n 100 CIED interrogations/programming
n 25 remote device interrogations
6 months
For Level II training, including pacemaker implantation
n 40 permanent pacemaker implantations with
at least 20 single-chamber and 20 dual-chamber
pacemakers
CIED ¼ cardiac implantable electrical device.
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months of dedicated Level II training in implanting per-
manent pacemakers. Level II training obtained during a
standard 3-year clinical cardiovascular fellowship does
not qualify the trainee to implant deﬁbrillators or biven-
tricular devices. Rather, deﬁbrillator and biventricular
device implantation requires Level III training in invasive
CCEP or an additional 12 months of dedicated training in
ICD and biventricular device implantation and manage-
ment. During this additional 12-month period, the volume
requirements for device programming and ICD and
biventricular device implants must be met. The core
competencies appropriate for Level II training, including
minimum procedural volume criteria, are outlined in
Table 3.
4.2.2.1. Optional Training in Pacemaker Implantation
(Level II)
Those who have obtained Level II training and wish to
implant permanent single- and dual-chamber pacemakers
should spend time implanting permanent pacemakers
during the 3-year cardiovascular fellowship program if 6
months is dedicated to acquiring the knowledge and skills
pertaining to permanent pacemaker implantation and
related patient management and follow-up. Competence
in the indications for, implantation techniques, and
follow-up of ILRs is desirable. This training does not
satisfy the ABIM requirements for admission to the CCEP
examination and is not considered adequate training to
implant implantable deﬁbrillators.
4.2.2.2. Training in Deﬁbrillator Implantation
Individuals who spend an additional 12 months (beyond a
standard 3-year cardiovascular fellowship) obtaining
additional training in ICD, biventricular device, and
pacemaker implantation without satisfying the full re-
quirements for Level III training in advanced cardiac
electrophysiology (Level III training) can be grantedprivileges to implant CIEDs, including ICDs and biven-
tricular devices. It is recommended that this type of
training for CIED implantation follow the aforementioned
COCATS requirements. Although these individuals are not
eligible for the ABIM EP Board Examination, they may be
candidates for the International Board of Heart Rhythm
Examiners physician examination (18).
4.2.3. Level III Training Requirements
The ACGME has deﬁned the essential components of a
specialized program for training in CCEP; the ABIM offers
an examination for this additional certiﬁcation. Informa-
tion concerning the eligibility requirements for the ex-
amination can be obtained from the ABIM. Privileges to
perform invasive procedures should be based mainly on
satisfactory completion of the training outlined in this
document, including demonstration of competence and
technical expertise.
Level III training prepares the physician to specialize in
invasive CCEP (5,19,20). Level III trainees should meet all
Level II training requirements and obtain additional,
advanced training in performing diagnostic EP pro-
cedures, catheter-based ablation procedures, and im-
plantation of ICDs and biventricular pacemakers. The
minimal procedure volume requirements are provided in
the Clinical Competency Statement (5,19,20). The Clinical
Competency Statement for training in electrophysiology
will be replaced by an ACC/American Heart Association/
HRS Electrophysiology Advanced Training Statement
currently under development. The appropriate use, safe
performance, and judicious interpretation of these com-
plex procedures require highly specialized training for
competence to be achieved. Advanced understanding of
CCEP and cardiac pharmacology is required along with the
technical and cognitive skills to manage patients with
complex arrhythmias.
Level III training should include performing diagnostic
EP procedures for a variety of indications, including
evaluation of syncope, determination of the precise
mechanism of supraventricular arrhythmias, and risk-
stratiﬁcation in patients with malignant arrhythmias. In
many patients, these diagnostic EP procedures may be
performed in conjunction with planned catheter ablation
procedures for treatment of supraventricular arrhyth-
mias. Level III training in EP requires experience in left
ventricular lead implantation procedures, ICD implanta-
tion, and performance of pacing and deﬁbrillation
threshold testing at the time of implantation and during
follow-up.
Level III training in preparation for the CCEP board ex-
amination includes training in implantable deﬁbrillator
implantation, during which the physician should develop
expertise in the placement of permanent atrial, right and
left ventricular, and ICD leads. Trainees should also
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subcutaneous ICDs. This entails adhering to principles
of surgical asepsis, mastering surgical implantation tech-
niques, and managing implant-related complications.
Trainees in implantable deﬁbrillator implantation should
acquire extensive knowledge of the indications for and
contraindications to ICDs; thorough understanding of
advanced ICD electrocardiography; knowledge of drug–
device interactions; competency in interrogation and
programming of complex pacemaker and ICD systems;
expertise in threshold testing, ventricular ﬁbrillation in-
duction, and deﬁbrillator testing; experience in managing
device-related complications; and competence in man-
aging high pacing, deﬁbrillation thresholds, and device
malfunction. Level III trainees gain extensive knowledge
of the indications for placement of left ventricular
leads, contraindications, and management of biven-
tricular device malfunctions and interactions. Because
competency in these procedures is related to caseload,
minimal procedural volumes must be satisﬁed during
Level III training.
5. EVALUATION OF COMPETENCY
Evaluation tools in cardiac arrhythmia diagnosis, pacing,
and electrophysiology include direct observation by in-
structors, in-training examinations, case logbooks, con-
ference and case presentations, multisource evaluations,
trainee portfolios, and simulation. Case management,
judgment, interpretive, and bedside skills must beevaluated in every trainee. Quality of care and follow-up;
reliability; judgment, decisions, or actions that result in
complications; interaction with other physicians, pa-
tients, and laboratory support staff; initiative; and the
ability to make appropriate decisions independently
should be considered. Trainees should maintain records
of participation and advancement in the form of a Health
Insurance Portability and Accountability Act (HIPAA)–
compliant electronic database or logbook that meets
ACGME reporting standards and summarizes pertinent
clinical information (e.g., number of cases, diversity of
referral sources, diagnoses, disease severity, outcomes,
and disposition).
The ACC, American Heart Association, and HRS have
formulated a clinical competence statement on invasive
EP studies, catheter ablation, and cardioversion (5).
Self-assessment programs and competence examina-
tions in ECG are available through the ACC and other
organizations. Training directors and trainees are
encouraged to incorporate these resources in the course
of training.
Under the aegis of the program director, the faculty
should record and verify each trainee’s experiences,
assess performance, and document satisfactory achieve-
ment. The program director is responsible for conﬁrming
experience and competence and reviewing the overall
progress of individual trainees, with the Clinical Compe-
tency Committee ensuring achievement of selected
training milestones and identifying areas in which addi-
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